These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18276943)

  • 1. Identification of target antigens of antifibroblast antibodies in pulmonary arterial hypertension.
    Terrier B; Tamby MC; Camoin L; Guilpain P; Broussard C; Bussone G; Yaïci A; Hotellier F; Simonneau G; Guillevin L; Humbert M; Mouthon L
    Am J Respir Crit Care Med; 2008 May; 177(10):1128-34. PubMed ID: 18276943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension.
    Tamby MC; Chanseaud Y; Humbert M; Fermanian J; Guilpain P; Garcia-de-la-Peña-Lefebvre P; Brunet S; Servettaz A; Weill B; Simonneau G; Guillevin L; Boissier MC; Mouthon L
    Thorax; 2005 Sep; 60(9):765-72. PubMed ID: 16135682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG from patients with pulmonary arterial hypertension and/or systemic sclerosis binds to vascular smooth muscle cells and induces cell contraction.
    Bussone G; Tamby MC; Calzas C; Kherbeck N; Sahbatou Y; Sanson C; Ghazal K; Dib H; Weksler BB; Broussard C; Verrecchia F; Yaici A; Witko-Sarsat V; Simonneau G; Guillevin L; Humbert M; Mouthon L
    Ann Rheum Dis; 2012 Apr; 71(4):596-605. PubMed ID: 22084393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibroblast antibodies from systemic sclerosis patients bind to {alpha}-enolase and are associated with interstitial lung disease.
    Terrier B; Tamby MC; Camoin L; Guilpain P; Bérezné A; Tamas N; Broussard C; Hotellier F; Humbert M; Simonneau G; Guillevin L; Mouthon L
    Ann Rheum Dis; 2010 Feb; 69(2):428-33. PubMed ID: 19293162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targets of anti-endothelial cell antibodies in pulmonary hypertension and scleroderma.
    Dib H; Tamby MC; Bussone G; Regent A; Berezné A; Lafine C; Broussard C; Simonneau G; Guillevin L; Witko-Sarsat V; Humbert M; Mouthon L
    Eur Respir J; 2012 Jun; 39(6):1405-14. PubMed ID: 22005913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension.
    Tamby MC; Humbert M; Guilpain P; Servettaz A; Dupin N; Christner JJ; Simonneau G; Fermanian J; Weill B; Guillevin L; Mouthon L
    Eur Respir J; 2006 Oct; 28(4):799-807. PubMed ID: 16774952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis.
    Becker MO; Kill A; Kutsche M; Guenther J; Rose A; Tabeling C; Witzenrath M; Kühl AA; Heidecke H; Ghofrani HA; Tiede H; Schermuly RT; Nickel N; Hoeper MM; Lukitsch I; Gollasch M; Kuebler WM; Bock S; Burmester GR; Dragun D; Riemekasten G
    Am J Respir Crit Care Med; 2014 Oct; 190(7):808-17. PubMed ID: 25181620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifibroblast antibodies from systemic sclerosis patients are internalized by fibroblasts via a caveolin-linked pathway.
    Ronda N; Gatti R; Giacosa R; Raschi E; Testoni C; Meroni PL; Buzio C; Orlandini G
    Arthritis Rheum; 2002 Jun; 46(6):1595-601. PubMed ID: 12115191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.
    Hénault J; Tremblay M; Clément I; Raymond Y; Senécal JL
    Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis.
    Chizzolini C; Raschi E; Rezzonico R; Testoni C; Mallone R; Gabrielli A; Facchini A; Del Papa N; Borghi MO; Dayer JM; Meroni PL
    Arthritis Rheum; 2002 Jun; 46(6):1602-13. PubMed ID: 12115192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension.
    Negi VS; Tripathy NK; Misra R; Nityanand S
    J Rheumatol; 1998 Mar; 25(3):462-6. PubMed ID: 9517764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis.
    Hofstee HM; Vonk Noordegraaf A; Voskuyl AE; Dijkmans BA; Postmus PE; Smulders YM; Serné EH
    Ann Rheum Dis; 2009 Feb; 68(2):191-5. PubMed ID: 18375538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension.
    Corrado A; Correale M; Mansueto N; Monaco I; Carriero A; Mele A; Colia R; Di Biase M; Cantatore FP
    Microvasc Res; 2017 Nov; 114():46-51. PubMed ID: 28619664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH.
    Clements PJ; Tan M; McLaughlin VV; Oudiz RJ; Tapson VF; Channick RN; Rubin LJ; Langer A;
    Ann Rheum Dis; 2012 Feb; 71(2):249-52. PubMed ID: 21998119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry.
    Hinchcliff M; Khanna S; Hsu VM; Lee J; Almagor O; Chang RW; Steen V; Chung L;
    Semin Arthritis Rheum; 2015 Dec; 45(3):309-14. PubMed ID: 26210782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Warfarin in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. A Bayesian approach to evaluating treatment for uncommon disease.
    Johnson SR; Granton JT; Tomlinson GA; Grosbein HA; Le T; Lee P; Seary ME; Hawker GA; Feldman BM
    J Rheumatol; 2012 Feb; 39(2):276-85. PubMed ID: 22247353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of target antigens of antiendothelial cell antibodies in healthy individuals: A proteomic approach.
    Servettaz A; Guilpain P; Camoin L; Mayeux P; Broussard C; Tamby MC; Tamas N; Kaveri SV; Guillevin L; Mouthon L
    Proteomics; 2008 Mar; 8(5):1000-8. PubMed ID: 18240136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies against phosphatidylserine-prothrombin complex in patients with systemic sclerosis.
    Hasegawa M; Sato S; Yanaba K; Komura K; Yamazaki M; Takehara K
    Ann Rheum Dis; 2004 Nov; 63(11):1514-7. PubMed ID: 15479907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble CD90 as a potential marker of pulmonary involvement in systemic sclerosis.
    Kollert F; Christoph S; Probst C; Budweiser S; Bannert B; Binder M; Sehnert B; Voll RE; Warnatz K; Zissel G; Walker UA; Prasse A; Saalbach A
    Arthritis Care Res (Hoboken); 2013 Feb; 65(2):281-7. PubMed ID: 22807289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis.
    Hayakawa I; Hasegawa M; Takehara K; Sato S
    Arch Dermatol Res; 2005 Oct; 297(4):180-3. PubMed ID: 16180014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.